Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Med (New York, N.Y.)
|
May 28, 2026
Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity
Miguel A Lopez-Lago, Meriem Taleb, Mehek Ningoo, et al.
The Lancet. Digital Health
|
August 1, 2021
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study
Marjorie G Zauderer, Axel Martin, Jacklynn Egger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features
Soo-Ryum Yang, Gowtham Jayakumaran, Jamal Benhamida, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors
Narek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2019
Lessons learned from routine, targeted assessment of liquid biopsies for <i>EGFR</i> T790M resistance mutation in patients with <i>EGFR</i> mutant lung cancers
Sebastian Mondaca, Michael Offin, Laetitia Borsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 11, 2021
Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling
Soo-Ryum Yang, Jason C Chang, Charles Leduc, et al.
The Journal of Molecular Diagnostics : JMD
|
April 17, 2022
Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations
Ying-Hsia Chu, Jada Barbee, Soo-Ryum Yang, et al.
Annals of Surgical Oncology
|
August 21, 2024
Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors
Michael Offin, Nicole Aguirre, Soo Ryum Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 11, 2021
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers
Igor Odintsov, Marissa S Mattar, Allan J W Lui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2021
Molecular Characterization of Peritoneal Mesotheliomas
Michael Offin, Soo-Ryum Yang, Jacklynn Egger, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Med (New York, N.Y.)
|
May 28, 2026
Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity
Miguel A Lopez-Lago, Meriem Taleb, Mehek Ningoo, et al.
The Lancet. Digital Health
|
August 1, 2021
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study
Marjorie G Zauderer, Axel Martin, Jacklynn Egger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features
Soo-Ryum Yang, Gowtham Jayakumaran, Jamal Benhamida, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors
Narek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2019
Lessons learned from routine, targeted assessment of liquid biopsies for <i>EGFR</i> T790M resistance mutation in patients with <i>EGFR</i> mutant lung cancers
Sebastian Mondaca, Michael Offin, Laetitia Borsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 11, 2021
Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling
Soo-Ryum Yang, Jason C Chang, Charles Leduc, et al.
The Journal of Molecular Diagnostics : JMD
|
April 17, 2022
Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations
Ying-Hsia Chu, Jada Barbee, Soo-Ryum Yang, et al.
Annals of Surgical Oncology
|
August 21, 2024
Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors
Michael Offin, Nicole Aguirre, Soo Ryum Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 11, 2021
Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers
Igor Odintsov, Marissa S Mattar, Allan J W Lui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2021
Molecular Characterization of Peritoneal Mesotheliomas
Michael Offin, Soo-Ryum Yang, Jacklynn Egger, et al.
Page
of 9